Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Establishes Pharma Subsidiary to Affirm Commitment to Personalized Medicine

NEW YORK, Oct. 12 (GenomeWeb News) - DNAPrint Genomics has established a subsidiary, called DNAPrint Pharmaceuticals, to focus on personalized medicine, the company said today.

 

DNAPrint, which develops genomics-based products and services, said it will also be seeking funding for DNAPrint Pharmaceuticals. Hector Gomez, DNAPrint's chairman and chief medical officer, said the new subsidiary "affirms" its "commitment to the development" of new drugs and tests.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.